Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Asthma Clinical Trials

A listing of Asthma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (44) clinical trials

Peninsula Research Associates, Inc. is seeking adults ages 18 and up with asthma to participate in a clinical research study. Study is comparing the effectiveness of a drug in patients with uncontrolled asthma.

Phase

We are conducting a clinical research study to determine the safety and effectiveness of an investigational drug and its ability to control asthma symptoms when added to certain asthma medications.

Phase

Peninsula Research Associate is seeking adults ages 18-65 with uncontrolled asthma.

Phase

Western States Clinical Research, Inc. and Dr. Jeffrey Rumbyrt are now enrolling in a clinical trial investigating the safety and efficacy of an investigational medication being compared to placebo for adults 18-75 years old, with severe, uncontrolled asthma despite use of standard asthma therapy. About the study medication: The study ...

Phase

We are currently looking for study participants who have been diagnosed with Asthma.

Phase

This study will be testing an investigational medication for asthma.

Phase

Northern California Research is conducting a study for adolescents (ages 12-18) who have chronic constipation. The purpose of this study is to find out the study medication has beneficial effect in adolescents who have CIC. This study medication is approved by the FDA for use in adults; the use of ...

Phase

Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma

At week 12 subjects not on oral corticosteroids (OCS) will complete the treatment period and return after 4 weeks for final follow up visit. Those subjects who were taking OCS at baseline will continue for a maximum of 12 additional weeks, double blind period during which their current OCS treatment ...

Phase

Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

The total study duration for each patient is between approximately 29 and maximum of 30 weeks, consisting of a screening period of 5 weeks and optional up to 7 additional days, a treatment period of 12 weeks, and a post-treatment period of 12 weeks. Patients who complete the treatment period ...

Phase

Single Dose Study to Evaluate the Safety and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma

Phase IIa, placebo-controlled, randomized, double-blind, crossover single dose study to evaluate the safety, tolerability and efficacy of S-1226 (8%) administered by nebulization in subjects with mild atopic asthma

Phase